What is xyAid's primary focus?

xyAid focuses on developing a method for ultrasonic separation of normal and abnormal spermatozoa to enrich the fraction of normal cells, aiming to increase fertility and assist with cell reproduction.

What is the status of xyAid?

xyAid is currently inactive, a status it has held since January 2018.

When was xyAid founded?

xyAid was founded in January 2015.

What is xyAid's employee count?

xyAid has 6 employees, falling within the 1-10 employee bucket.

Who are the co-founders of xyAid?

The co-founders of xyAid are Zachariah Gershon, who serves as Co-Founder & CEO, and Abba Priev, PhD, who is the Co-Founder & CSO.

In which sector does xyAid primarily operate?

xyAid's primary sector is Health Tech & Life Sciences, with additional classifications in Medical Devices and Medical Treatment & Therapeutics.

What is the current funding stage of xyAid?

xyAid is currently in the Pre-Funding stage.

xyAid

Morphology Ultrasonic Sperm Enrichment

Health Tech & Life Sciences

Stealth Mode

Pre-Funding Jerusalem, Israel Founded 2015

Last updated 2026-06-18

Total raised

—

Stage

Pre-Funding

Founded

2015

Headcount

Jerusalem, Israel

Sector

Health Tech & Life Sciences

About

XyAid develops a method of ultrasonic separation between normal andabnormal spermatozoa. The separation process isbased on differentmorphological structures andconcentrations of the normal and abnormal spermatozoa. The UV treatmentsubstantially enriches the fraction of normal cells, which increases fertility and assists with cell reproduction. XyAid's technology is named Assisted Reproduction Technologies and is relevant for intrauterine insemination, in-vitro fertilization, and intro cytoplasmic sperm injection.

Q&A

What is xyAid's primary focus?: xyAid focuses on developing a method for ultrasonic separation of normal and abnormal spermatozoa to enrich the fraction of normal cells, aiming to increase fertility and assist with cell reproduction.
What is the status of xyAid?: xyAid is currently inactive, a status it has held since January 2018.
When was xyAid founded?: xyAid was founded in January 2015.
What is xyAid's employee count?: xyAid has 6 employees, falling within the 1-10 employee bucket.
Who are the co-founders of xyAid?: The co-founders of xyAid are Zachariah Gershon, who serves as Co-Founder & CEO, and Abba Priev, PhD, who is the Co-Founder & CSO.
In which sector does xyAid primarily operate?: xyAid's primary sector is Health Tech & Life Sciences, with additional classifications in Medical Devices and Medical Treatment & Therapeutics.
What is the current funding stage of xyAid?: xyAid is currently in the Pre-Funding stage.

Team · 2

Zachariah Gershon

Founder · Co-Founder & CEO

Abba Priev, PhD

Founder · Co-Founder & CSO

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics

Technologies

Simulation & ImagingUltrasound

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

Highlights

1 Patents

Identifiers & details

Founded	2015-1
Employees (exact)	6
Status reason	Non Active, Jan 2018

About

Q&A

Team · 2

Sectors & technology

Highlights

Tags

Identifiers & details

Generate Slim Page